Astragalus membranaceus improves endothelial-dependent vasodilator function in obese rats.
- Author:
Ming-rui LI
1
;
Ye-rong YU
;
Gang DENG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Aorta, Thoracic; pathology; Astragalus membranaceus; chemistry; Drugs, Chinese Herbal; pharmacology; Endothelium, Vascular; drug effects; pathology; physiopathology; Endothelium-Dependent Relaxing Factors; therapeutic use; In Vitro Techniques; Insulin Resistance; Male; Obesity; physiopathology; Phytotherapy; Random Allocation; Rats; Rats, Sprague-Dawley; Vasodilator Agents; pharmacology
- From: Journal of Southern Medical University 2010;30(1):7-10
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of Astragalus membranaceus (AM) on endothelial-dependent (EDV) and non- dependent (EIV) vascular relaxation in ex vivo thoracic aortic rings of obese rats.
METHODSFifteen SD rats were randomized into 3 equal groups, namely the control group fed with normal chow, obese group with high-fat chow, and AM intervention group fed with high-fat chow and daily AM gavage. The rats were sacrificed after 6 weeks of feeding, and the aortic rings were dissected and cut into 3-mm rings. The response to acethylcholine (Ach) and sodium nitroprusside (SNP) were examined in organ bath. In ex vivo study, the aortic rings obtained from the control group and obese group were incubated with AM or vehicle for 3 h in organ bath before testing the EDV and EIV. The body weight and weight of the visceral fat in each group were recorded.
RESULTSThe weight of visceral fat was greater in the obese group than in the control group, and a 6-week AM treatment significantly reduced the fat tissue due to high-fat diet. The maximum EDV value was (87.0 - or + 3.5)% in the control group, (54.8 - or + 7.8)% in the obese group, and (69.8 - or + 5.7)% in AM intervention group; the EIV values were comparable between the 3 groups. After incubation with AM, the maximum EDV values of aortic rings obtained from the obese group were significantly increased from (55.6 - or + 8.3)% to (85.1 - or + 4.5)%.
CONCLUSIONAM can improve endothelial dysfunction in obese rats, and the mechanism involves improved insulin resistance and increased endothelium-derived NO productor function.